Skip to content

Li-Fen Chen

5 papers in the library · 56 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

Shorter to be effective: subanesthetic-dose ketamine infusion reduces the global and regional path length of brain functional connectivity in patients with treatment-resistant depression and suicidal ideation.

Psychopharmacology (Berl) May 22, 2026 Wei-Chen Lin, Li-Kai Cheng, Tung-Ping Su et al.

Shorter to be effective: subanesthetic-dose ketamine infusion reduces the global and regional path length of brain functional connectivity in patients with treatment-resistant depression and suicidal ideation.

Effect of ketamine intervention on hemodynamic responses in patients with treatment-resistant depression.

Scientific Reports May 20, 2026 Guan-Jie She, Wei-Chi Li, Chun-Hsiang Chou et al.

Emerging evidence shows that ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, can produce rapid anti-suicidal effects in treatment-resistant depression, yet its underlying neuropharmacological mechanisms remain elusive. The present study aimed at investigating the therapeutic effect of ketamine infusion on suicidal ideation by examining hemodynamic response changes in resting-state...

Triple-network model-based graph theory analysis of the effectiveness of low-dose ketamine in patients with treatment-resistant depression: two resting-state functional MRI clinical trials.

The British journal of psychiatry : the journal of mental science April 2, 2025 Wei-Chen Lin, Li-Kai Cheng, Tung-Ping Su et al. 2 citations

Evidence suggests the crucial role of dysfunctional default mode (DMN), salience and frontoparietal (FPN) networks, collectively termed the triple network model, in the pathophysiology of treatment-resistant depression (TRD). Using the graph theory- and seed-based functional connectivity analyses, we attempted to elucidate the role of low-dose ketamine in the triple networks, namely the DMN,...

Low-dose ketamine improved brain network integrity among patients with treatment-resistant depression and suicidal ideation.

Psychiatry Research March 1, 2025 Tung-Ping Su, Li-Kai Cheng, Pei-Chi Tu et al. 6 citations

Ketamine is a dissociative drug used for the treatment of depression. However, the neurofunctional mechanism underlying the antidepressant effect of ketamine remains unknown. According to previous research, low-dose ketamine affects large-scale brain networks, including default-mode and salient networks. A total of 43 patients with treatment-resistant depression (TRD) and suicidal ideation (SI)...

A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation

International Journal of Neuropsychopharmacology March 26, 2023 T. Su, Cheng-Ta Li, Wei-Chen Lin et al. 48 citations

Abstract Background The benefits of low-dose ketamine for patients with treatment-resistant depression (TRD) and prominent suicidal ideation require further investigation. The effects of treatment refractoriness, the duration of the current depressive episode, and the number of prior antidepressant failures on ketamine efficacy also require clarification. Methods We recruited 84 outpatients...